Multiplex Assay Market by Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), Product (Reagents & Consumables, Instruments & Accessories, and Software & Services), Application (Clinical Diagnostics, Research & Development, and Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030
The global multiplex assay market was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 to 2030.
The multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
The multiplex assays market is witnessing tremendous growth owing to increase in R&D activities in pharmaceuticals for the treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases, and automated as compared to conventional methods, thus fueling the market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth.
The global multiplex assays market in this report is studied based on type, product, application, end user, and region. On the basis of type, the market is divided protein based multiplex assays, nucleic acid-based multiplex assay, and other multiplex assays. By product, the market is classified into reagents & consumables, instruments & accessories, software & services.
The applications covered in the study include clinical diagnostics, research & development, and companion diagnostics. As per end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceutical & biotechnology companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major factors driving the market are increasing use of multiplex assays in companion diagnostics, increasing advantages over singleplex and traditional assays, increasing incidence of chronic and infectious diseases, and growing awareness about early disease diagnosis. In addition, growing adoption of personalized medicine, and a wide range of advantages of multiplex assays over traditional assays are positively impacting the growth of the multiplex assay market.
However, dearth of skilled professionals is expected to create hindrances for the growth of the multiplex assay market. Moreover, high procurement and operational costs along with the cumbersome and complex nature of multiplex assay instruments remain a significant hurdle in the multiplex assay market.
Increasing validation of the biomarkers in molecular and protein diagnostics, along with the rising need of the high-throughput and automated systems which are creating lucrative opportunities in the multiplex assay market.
Region wise, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the multiplex assays market in 2020, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the increase in government funds for the detection of new biomarkers, rise in R&D activates of new drugs and diagnosis & treatment options, as well as surge in prevalence of chronic diseases such as cancer and strokes.
The major players operating in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
KEY BENEFITS FOR STAKEHOLDERS
The report provides in-depth analysis of the global multiplex assay market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global multiplex assay market growth.
KEY MARKET SEGMENTS
By Type
Protein-Based Multiplex Assays
Nucleic Acid-Based Multiplex Assay
Other multiplex Assays
By Product
Reagents & Consumables
Instruments & Accessories
Software & Services
By application
Clinical Diagnostics
Research & Development
Companion Diagnostics
By End Users
Hospitals
Clinical Laboratories
Research Institutes
Pharmaceuticals & Biotechnological Companies
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of key players profiled in the report:
Luminex Corporation
Thermo Fisher Scientific Inc.
Illumina Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Becton, Dickinson and Company
Abcam PLC
Seegene Inc.
Meso Scale Diagnostics LLC
Randox Laboratories Ltd.
List of Company Profiles
Luminex Corporation
Thermo Fisher Scientific Inc.
Illumina Inc.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Becton
Dickinson and Company
Abcam PLC
Seegene Inc.
Meso Scale Diagnostics LLC
Randox Laboratories Ltd.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key benefits for stakeholders
- 1.3.Key market segments
- 1.4.Research methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.2.2.Top winning strategies
- 3.3.Porter’s five force analysis
- 3.4.Top player positioning, 2020
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.1.1.Increase in R&D activities & government funding
- 3.5.1.2.Surge in adoption of multiplex assays to reduce operation costs
- 3.5.1.3.Rise in adoption of personalized medicines
- 3.5.2.Restraint
- 3.5.2.1.Lack of skilled labor/healthcare professionals
- 3.5.3.Opportunity
- 3.5.3.1.Various growth opportunities in emerging economies
- 3.6.COVID-19 impact analysis on multiplex assay market
- CHAPTER 4:MULTIPLEX ASSAY MARKET, BY TYPE
- 4.1.Overview
- 4.1.1.Market size and forecast
- 4.2.Protein based multiplex assays
- 4.2.1.Key market trends and opportunities
- 4.2.2.Market size and forecast, by region
- 4.2.3.Market analysis, by country
- 4.3.Nucleic Acid-Based Multiplex Assay
- 4.3.1.Key market trends and opportunities
- 4.3.2.Market size and forecast, by region
- 4.3.3.Market analysis, by country
- 4.4.Other multiplex assays
- 4.4.1.Key market trends and opportunities
- 4.4.2.Market size and forecast, by region
- 4.4.3.Market analysis, by country
- CHAPTER 5:MULTIPLEX ASSAY MARKET, BY PRODUCT
- 5.1.Overview
- 5.1.1.Market size and forecast
- 5.2.Reagents and Consumables
- 5.2.1.Key market trends and opportunities
- 5.2.2.Market size and forecast, by region
- 5.2.3.Market analysis, by country
- 5.3.Instruments and Accessories
- 5.3.1.Key market trends and opportunities
- 5.3.2.Market size and forecast, by region
- 5.3.3.Market analysis, by country
- 5.4.Software & Services
- 5.4.1.Key market trends and opportunities
- 5.4.2.Market size and forecast, by region
- 5.4.3.Market analysis, by country
- CHAPTER 6:MULTIPLEX ASSAY MARKET, BY APPLICATION
- 6.1.Overview
- 6.1.1.Market size and forecast
- 6.2.Clinical Diagnostics
- 6.2.1.Market size and forecast, by region
- 6.2.2.Market analysis, by country
- 6.3.Research and development
- 6.3.1.Market size and forecast, by region
- 6.3.2.Market analysis, by country
- 6.4.Companion Diagnostics
- 6.4.1.Market size and forecast, by region
- 6.4.2.Market analysis, by country
- CHAPTER 7:MULTIPLEX ASSAY MARKET, BY END USER
- 7.1.Overview
- 7.1.1.Market size and forecast
- 7.2.Hospitals
- 7.2.1.Market size and forecast, by region
- 7.2.2.Market analysis, by country
- 7.3.Clinical Laboratories
- 7.3.1.Market size and forecast, by region
- 7.3.2.Market analysis, by country
- 7.4.Research Institutes
- 7.4.1.Market size and forecast, by region
- 7.4.2.Market analysis, by country
- 7.5.Pharmaceutical & biotechnology companies
- 7.5.1.Market size and forecast, by region
- 7.5.2.Market analysis, by country
- CHAPTER 8:MULTIPLEX ASSAY MARKET, BY REGION
- 8.1.Overview
- 8.1.1.Market size and forecast
- 8.2.North America
- 8.2.1.Key market trends, growth factors, and opportunities
- 8.2.2.Market size and forecast, by country
- 8.2.2.1.U.S.
- 8.2.2.1.1.U.S. Multiplex Assay Market, by type
- 8.2.2.1.2.U.S. Multiplex Assay Market, by product
- 8.2.2.1.3.U.S. Multiplex Assay Market, by application
- 8.2.2.1.4.U.S. Multiplex Assay Market, by end user
- 8.2.2.2.Canada
- 8.2.2.2.1.Canada Multiplex Assay Market, by type
- 8.2.2.2.2.Canada Multiplex Assay Market, by product
- 8.2.2.2.3.Canada Multiplex Assay Market, by application
- 8.2.2.2.4.Canada Multiplex Assay Market, by end user
- 8.2.2.3.Mexico
- 8.2.2.3.1.Mexico Multiplex Assay Market, by type
- 8.2.2.3.2.Mexico Multiplex Assay Market, by product
- 8.2.2.3.3.Mexico Multiplex Assay Market, by application
- 8.2.2.3.4.Mexico Multiplex Assay Market, by end user
- 8.2.3.North America market size and forecast, by type
- 8.2.4.North America market size and forecast, by product
- 8.2.5.North America market size and forecast, by application
- 8.2.6.North America market size and forecast, by end user
- 8.3.Europe
- 8.3.1.Key market trends, growth factors, and opportunities
- 8.3.2.Market size and forecast, by country
- 8.3.2.1.Germany
- 8.3.2.1.1.Germany Multiplex Assay Market, by type
- 8.3.2.1.2.Germany Multiplex Assay Market, by product
- 8.3.2.1.3.Germany Multiplex Assay Market, by application
- 8.3.2.1.4.Germany Multiplex Assay Market, by end user
- 8.3.2.2.France
- 8.3.2.2.1.France Multiplex Assay Market, by type
- 8.3.2.2.2.France Multiplex Assay Market, by product
- 8.3.2.2.3.France Multiplex Assay Market, by application
- 8.3.2.2.4.France Multiplex Assay Market, by end user
- 8.3.2.3.UK
- 8.3.2.3.1.UK Multiplex Assay Market, by type
- 8.3.2.3.2.UK Multiplex Assay Market, by product
- 8.3.2.3.3.UK Multiplex Assay Market, by application
- 8.3.2.3.4.UK Multiplex Assay Market, by end user
- 8.3.2.4.Italy
- 8.3.2.4.1.Italy Multiplex Assay Market, by type
- 8.3.2.4.2.Italy Multiplex Assay Market, by product
- 8.3.2.4.3.Italy Multiplex Assay Market, by application
- 8.3.2.4.4.Italy Multiplex Assay Market, by end user
- 8.3.2.5.Spain
- 8.3.2.5.1.Spain Multiplex Assay Market, by type
- 8.3.2.5.2.Spain Multiplex Assay Market, by product
- 8.3.2.5.3.Spain Multiplex Assay Market, by application
- 8.3.2.5.4.Spain Multiplex Assay Market, by end user
- 8.3.2.6.Rest of Europe
- 8.3.2.6.1.Rest of Europe Multiplex Assay Market, by type
- 8.3.2.6.2.Rest of Europe Multiplex Assay Market, by product
- 8.3.2.6.3.Rest of Europe Multiplex Assay Market, by application
- 8.3.2.6.4.Rest of Europe Multiplex Assay Market, by end user
- 8.3.3.Europe market size and forecast, by type
- 8.3.4.Europe market size and forecast, by product
- 8.3.5.Europe market size and forecast, by application
- 8.3.6.Europe market size and forecast, by end user
- 8.4.Asia-Pacific
- 8.4.1.Key market trends, growth factors, and opportunities
- 8.4.2.Market size and forecast, by country
- 8.4.2.1.Japan
- 8.4.2.1.1.Japan Multiplex Assay Market, by type
- 8.4.2.1.2.Japan Multiplex Assay Market, by product
- 8.4.2.1.3.Japan Multiplex Assay Market, by application
- 8.4.2.1.4.Japan Multiplex Assay Market, by end user
- 8.4.2.2.China
- 8.4.2.2.1.China Multiplex Assay Market, by type
- 8.4.2.2.2.China Multiplex Assay Market, by product
- 8.4.2.2.3.China Multiplex Assay Market, by application
- 8.4.2.2.4.China Multiplex Assay Market, by end user
- 8.4.2.3.Australia
- 8.4.2.3.1.Australia Multiplex Assay Market, by type
- 8.4.2.3.2.Australia Multiplex Assay Market, by product
- 8.4.2.3.3.Australia Multiplex Assay Market, by application
- 8.4.2.3.4.Australia Multiplex Assay Market, by end user
- 8.4.2.4.India
- 8.4.2.4.1.India Multiplex Assay Market, by type
- 8.4.2.4.2.India Multiplex Assay Market, by product
- 8.4.2.4.3.India Multiplex Assay Market, by application
- 8.4.2.4.4.India Multiplex Assay Market, by end user
- 8.4.2.5.Rest of Asia-Pacific
- 8.4.2.5.1.Rest of Asia-Pacific Multiplex Assay Market, by type
- 8.4.2.5.2.Rest of Asia-Pacific Multiplex Assay Market, by product
- 8.4.2.5.3.Rest of Asia-Pacific Multiplex Assay Market, by application
- 8.4.2.5.4.Rest of Asia-Pacific Multiplex Assay Market, by end user
- 8.4.3.Asia-Pacific market size and forecast, by type
- 8.4.4.Asia-Pacific market size and forecast, by product
- 8.4.5.Asia-Pacific market size and forecast, by application
- 8.4.6.Asia-Pacific market size and forecast, by end user
- 8.5.LAMEA
- 8.5.1.Key market trends, growth factors, and opportunities
- 8.5.2.Market size and forecast, by country
- 8.5.2.1.Brazil
- 8.5.2.1.1.Brazil Multiplex Assay Market, by type
- 8.5.2.1.2.Brazil Multiplex Assay Market, by product
- 8.5.2.1.3.Brazil Multiplex Assay Market, by application
- 8.5.2.1.4.Brazil Multiplex Assay Market, by end user
- 8.5.2.2.Saudi Arabia
- 8.5.2.2.1.Saudi Arabia Multiplex Assay Market, by type
- 8.5.2.2.2.Saudi Arabia Multiplex Assay Market, by product
- 8.5.2.2.3.Saudi Arabia Multiplex Assay Market, by application
- 8.5.2.2.4.Saudi Arabia Multiplex Assay Market, by end user
- 8.5.2.3.South Africa
- 8.5.2.3.1.South Africa Multiplex Assay Market, by type
- 8.5.2.3.2.South Africa Multiplex Assay Market, by product
- 8.5.2.3.3.South Africa Multiplex Assay Market, by application
- 8.5.2.3.4.South Africa Multiplex Assay Market, by end user
- 8.5.2.4.Rest of LAMEA
- 8.5.2.4.1.Rest of LAMEA Multiplex Assay Market, by type
- 8.5.2.4.2.Rest of LAMEA Multiplex Assay Market, by product
- 8.5.2.4.3.Rest of LAMEA Multiplex Assay Market, by application
- 8.5.2.4.4.Rest of LAMEA Multiplex Assay Market, by end user
- 8.5.3.LAMEA market size and forecast, by type
- 8.5.4.LAMEA market size and forecast, by product
- 8.5.5.LAMEA market size and forecast, by application
- 8.5.6.LAMEA market size and forecast, by end user
- CHAPTER 9:COMPANY PROFILES
- 9.1.ABCAM PLC.
- 9.1.1.Company overview
- 9.1.2.Company snapshot
- 9.1.3.Operating business segments
- 9.1.4.Product portfolio
- 9.1.5.Business performance
- 9.1.6.Key strategic moves and developments
- 9.2.BECTON, DICKINSON, AND COMPANY (BD BIOSCIENCES)
- 9.2.1.Company overview
- 9.2.2.Company snapshot
- 9.2.3.Operating business segments
- 9.2.4.Product portfolio
- 9.2.5.Business performance
- 9.2.6.Key strategic moves and developments
- 9.3.MESO SCALE DIAGNOSTICS LLC
- 9.3.1.Company overview
- 9.3.2.Company snapshot
- 9.3.3.Operating business segments
- 9.3.4.Product portfolio
- 9.4.SEEGENE INC.
- 9.4.1.Company overview
- 9.4.2.Company snapshot
- 9.4.3.Operating business segments
- 9.4.4.Product portfolio
- 9.5.BIO-RAD LABORATORIES, INC.
- 9.5.1.Company overview
- 9.5.2.Company snapshot
- 9.5.3.Operating business segments
- 9.5.4.Product portfolio
- 9.5.5.Business performance
- 9.5.6.Key strategic moves and developments
- 9.6.ILLUMINA, INC.
- 9.6.1.Company overview
- 9.6.2.Company snapshot
- 9.6.3.Operating business segments
- 9.6.4.Product portfolio
- 9.6.5.Business performance
- 9.6.6.Key strategic moves and developments
- 9.7.QIAGEN N.V.
- 9.7.1.Company overview
- 9.7.2.Company snapshot
- 9.7.3.Operating business segments
- 9.7.4.Product portfolio
- 9.7.5.Business performance
- 9.7.6.Key strategic moves and developments
- 9.8.THERMO FISHER SCIENTIFIC, INC.
- 9.8.1.Company overview
- 9.8.2.Company snapshot
- 9.8.3.Operating business segments
- 9.8.4.Product portfolio
- 9.8.5.Business performance
- 9.8.6.Key strategic moves and developments
- 9.9.LUMINEX CORPORATION
- 9.9.1.Company overview
- 9.9.2.Company snapshot
- 9.9.3.Operating business segments
- 9.9.4.Product portfolio
- 9.9.5.Business performance
- 9.9.6.Key strategic moves and developments
- 9.10.RANDOX LABORATORIES LTD.
- 9.10.1.Company overview
- 9.10.2.Company snapshot
- 9.10.3.Operating business segments
- 9.10.4.Product portfolio
- LIST OF TABLES
- TABLE 01.MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 02.MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
- TABLE 03.MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY REGION, 2020–2030 ($MILLION)
- TABLE 04.MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
- TABLE 05.MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 06.MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020–2030 ($MILLION)
- TABLE 07.MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2020–2030 ($MILLION)
- TABLE 08.MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020–2030 ($MILLION)
- TABLE 09.MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 10.MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
- TABLE 11.MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2020–2030 ($MILLION)
- TABLE 12.MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
- TABLE 13.MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 14.MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2020–2030 ($MILLION)
- TABLE 15.MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020–2030 ($MILLION)
- TABLE 16.MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020–2030 ($MILLION)
- TABLE 17.MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2030 ($MILLION)
- TABLE 18.MULTIPLEX ASSAY MARKET, BY REGION, 2020–2030 ($MILLION)
- TABLE 19.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
- TABLE 20.U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 21.U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 22.U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 23.U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 24.CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 25.CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 26.CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 27.CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 28.MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 29.MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 30.MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 31.MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 32.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 33.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 34.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 35.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 36.EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
- TABLE 37.GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 38.GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 39.GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 40.GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 41.FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 42.FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 43.FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 44.FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 45.UK MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 46.UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 47.UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 48.UK MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 49.ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 50.ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 51.ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 52.ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 53.SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 54.SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 55.SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 56.SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 57.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 58.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 59.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 60.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 61.EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 62.EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 63.EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 64.EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 65.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
- TABLE 66.JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 67.JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 68.JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 69.JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 70.CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 71.CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 72.CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 73.CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 74.AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 75.AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 76.AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 77.AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 78.INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 79.INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 80.INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 81.INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 82.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 83.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 84.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 85.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 86.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 87.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 88.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 89.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 90.LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
- TABLE 91.BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 92.BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 93.BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 94.BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 95.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 96.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 97.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 98.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 99.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 100.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 101.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 102.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 103.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 104.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 105.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 106.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 107.LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
- TABLE 108.LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
- TABLE 109.LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
- TABLE 110.LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
- TABLE 111.ABCAM PLC.: COMPANY SNAPSHOT
- TABLE 112.ABCAM PLC.: OPERATING SEGMENTS
- TABLE 113.ABCAM PLC.: PRODUCT PORTFOLIO
- TABLE 114.ABCAM PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 119.MESO SCALE DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 120.MESO SCALE DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 121.MESO SCALE DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 122.SEEGENE: COMPANY SNAPSHOT
- TABLE 123.SEEGENE: OPERATING SEGMENTS
- TABLE 124.SEEGENE: PRODUCT PORTFOLIO
- TABLE 125.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 126.BIO-RAD LABORATORIES: OPERATING SEGMENTS
- TABLE 127.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 128.BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 129.ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 130.ILLUMINA INC.: OPERATING SEGMENTS
- TABLE 131.ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 132.ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133.QIAGEN: COMPANY SNAPSHOT
- TABLE 134.QIAGEN NV: OPERATING SEGMENTS
- TABLE 135.QIAGEN NV: PRODUCT PORTFOLIO
- TABLE 136.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 137.THERMO FISHER: COMPANY SNAPSHOT
- TABLE 138.THERMO FISHER: OPERATING SEGMENTS
- TABLE 139.THERMO FISHER: PRODUCT PORTFOLIO
- TABLE 140.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 141.LUMINEX CORPORATION: COMPANY SNAPSHOT
- TABLE 142.LUMINEX CORPORATION: OPERATING SEGMENTS
- TABLE 143.LUMINEX CORPORATION: PRODUCT PORTFOLIO
- TABLE 144.LUMINEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 145.RANDOX: COMPANY SNAPSHOT
- TABLE 146.RANDOX OPERATING SEGMENTS
- TABLE 147.RANDOX: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01.MULTIPLEX ASSAY MARKET SEGMENTATION
- FIGURE 02.TOP INVESTMENT POCKETS, 2020
- FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
- FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
- FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
- FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 08.MODERATE THREAT OF SUBSTITUTES
- FIGURE 09.LOW THREAT OF NEW ENTRANTS
- FIGURE 10.MODERATE COMPETITIVE RIVALRY
- FIGURE 11.TOP PLAYER POSITIONING, 2020
- FIGURE 12.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 13.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 14.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 15.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 16.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 17.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 18.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 19.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 20.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 21.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 22.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 23.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 24.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
- FIGURE 25.ABCAM PLC.: NET SALES, 2018–2020 ($ MILLION)
- FIGURE 26.ABCAM PLC. REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 27.BECTON, DICKINSON AND COMPANY: NET SALES, 2018–2020 ($ MILLION)
- FIGURE 28.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 29.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 30.BIO-RAD LABORATORIES: NET SALES, 2018–2020 ($ MILLION)
- FIGURE 31.BIO-RAD LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 32.BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 33.ILLUMINA, INC.: NET SALES, 2018–2020 ($ MILLION)
- FIGURE 34.ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 35.ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 36.QIAGEN NV: NET SALES, 2020–2030 ($ MILLION)
- FIGURE 37.QIAGEN: REVENUE SHARE BY PRODUCT, 2020 (%)
- FIGURE 38.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 39.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
- FIGURE 40.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
- FIGURE 41.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
- FIGURE 42.LUMINEX CORPORATION: NET SALES, 2018–2020 ($MILLION)
- FIGURE 43.LUMINEX CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook